Molldrem, Jeffrey J.
The University of Texas MD Anderson Cancer Center,
United States
2025 Rank: 114,662
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3,019 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114,662 | 117,962 |
| Total Cites | 10,158 | 11,704 |
| H-index | 50 | 53 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 37 | 41 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 1,915 | 2,208 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 2,947 | 3,398 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,463 | 9,314 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.26 |
| Self-Citation Percentage |
13.21%
|
|
Molldrem, Jeffrey J.
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 108,277
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,931 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108,277 | 111,187 |
| Total Cites | 9,650 | 11,145 |
| H-index | 50 | 53 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 36 | 40 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,896 | 2,186 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 2,866 | 3,304 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,992 | 8,810 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
13.41%
|
|
Molldrem, Jeffrey J.
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 102,771
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,829 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102,771 | 105,800 |
| Total Cites | 9,116 | 10,575 |
| H-index | 49 | 51 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 36 | 40 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,883 | 2,172 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 2,801 | 3,236 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,483 | 8,278 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
13.80%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,737 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97,569 | 98,648 |
| Total Cites | 8,526 | 9,937 |
| H-index | 46 | 50 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 35 | 39 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,866 | 2,153 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 2,724 | 3,154 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,936 | 7,691 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.29 |
| Self-Citation Percentage |
14.20%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,634 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93,479 | 95,620 |
| Total Cites | 8,187 | 9,560 |
| H-index | 46 | 49 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 35 | 39 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,833 | 2,111 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 2,645 | 3,065 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,640 | 7,374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.30 |
| Self-Citation Percentage |
14.36%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,594 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,684 | 93,210 |
| Total Cites | 7,454 | 8,774 |
| H-index | 42 | 46 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 34 | 38 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 1,796 | 2,071 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 2,528 | 2,939 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,981 | 6,675 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
15.04%
|
|
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.